Heart Attack Clinical Trials

Find Heart Attack Clinical Trials Near You

Plaque Prediction Obtained With Shear Stress Endothelial Metrics: A Proof of Principle Study

Status: Recruiting
Location: See location...
Intervention Type: Procedure, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Coronary artery disease occurs when fatty deposits (plaques) build up inside the arteries that supply blood to the heart. Some plaques remain stable, while others continue to grow or become more likely to rupture, which can lead to a heart attack. Identifying plaques that are at higher risk of progression could help doctors provide earlier and more personalized treatment. The purpose of this study is to determine whether combining information about blood flow within the coronary arteries with information about a person's biological response to blood flow can improve prediction of plaque growth. Participants undergoing treatment for coronary artery disease will have a specialized heart scan to assess blood flow patterns around plaques in their coronary arteries. Researchers will also collect blood samples to study cells that line blood vessels and investigate how these cells respond to blood flow forces. The study will follow participants over time to determine whether plaques are more likely to progress in individuals who show a stronger biological response to abnormal blood flow. The findings may help researchers develop new ways to identify patients at higher risk of future heart problems and support the development of more personalized approaches to prevention and treatment of coronary artery disease.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Healthy Volunteers: f
View:

• Age ≥40

• Stable angina, defined as typical symptoms with evidence of reversible ischemia in non-invasive test and/or documented obstructive coronary artery disease on coronary angiography (\>70% stenosis of at least one major epicardial coronary artery or positive fractional flow reserve study)

• Patient that is willing and can provide written informed consent.

Locations
Other Locations
United Kingdom
Queen Marys University London
RECRUITING
London
Contact Information
Primary
Paul C Evans
paul.evans@qmul.ac.uk
+447825611695
Time Frame
Start Date: 2026-09-17
Estimated Completion Date: 2031-09-17
Participants
Target number of participants: 270
Treatments
Other: Single arm
Related Therapeutic Areas
Sponsors
Leads: Queen Mary University of London
Collaborators: Barts & The London NHS Trust

This content was sourced from clinicaltrials.gov